Low-Fat Breakfasts Could Weaken Effect of a Key Lung Cancer Drug

WEDNESDAY, June 14, 2023 -- The lung cancer drug alectinib (Alecensa) is more potent when taken with a fuller breakfast, or lunch, than when taken with a low-fat breakfast, researchers report.
The Dutch team evaluated 20 patients who took one of two...